Abstract
We present an integromic analysis of gene alterations that modulate transforming growth factor β (TGF-β)-Smad-mediated signaling in 9,125 tumor samples across 33 cancer types in The Cancer Genome Atlas (TCGA). Focusing on genes that encode mediators and regulators of TGF-β signaling, we found at least one genomic alteration (mutation, homozygous deletion, or amplification) in 39% of samples, with highest frequencies in gastrointestinal cancers. We identified mutation hotspots in genes that encode TGF-β ligands (BMP5), receptors (TGFBR2, AVCR2A, and BMPR2), and Smads (SMAD2 and SMAD4). Alterations in the TGF-β superfamily correlated positively with expression of metastasis-associated genes and with decreased survival. Correlation analyses showed the contributions of mutation, amplification, deletion, DNA methylation, and miRNA expression to transcriptional activity of TGF-β signaling in each cancer type. This study provides a broad molecular perspective relevant for future functional and therapeutic studies of the diverse cancer pathways mediated by the TGF-β superfamily.
Original language | English |
---|---|
Pages (from-to) | 422-437.e7 |
Journal | Cell systems |
Volume | 7 |
Issue number | 4 |
DOIs | |
Publication status | Published - 24 Oct 2018 |
Externally published | Yes |
Keywords
- Bone Morphogenetic Protein 5/genetics
- DNA Methylation
- Humans
- MicroRNAs/genetics
- Mutation Rate
- Neoplasms/genetics
- Receptor, Transforming Growth Factor-beta Type I/genetics
- Signal Transduction
- Smad Proteins/genetics
- Transforming Growth Factor beta/genetics